DB10785ApprovedInvestigationalVaccines
Neisseria meningitidis serogroup b nada protein antigen: Overview.
- First approval
- Canada, 2015 · United States, 2015 · European Union, 2013
- Also known as
- Neisseria meningitidis serogroup B recombinant NADA fusion protein antigen
- Brand names
Resolves to
Compound
Clinical / RWD
What you can answer from here — as of April 02, 2025
Which companies are running trials of Neisseria meningitidis serogroup b nada protein antigen, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account